Skip to content
Other

Finance Lease Liability Undiscounted Excess Amount

Moderna Finance Lease Liability Undiscounted Excess Amount decreased by 33.3% to $2M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 50.0%, from $4M to $2M.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ1 2020
Last reportedQ1 2026May 1, 2026
Metric ID: other_finance_lease_liability_undiscounted_excess_amount

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$444M$440M$578M$573M$596M$653M$653M$615M$603M$597M$597M$4M$4M$3M$2M
QoQ Change-0.9%+31.4%-0.9%+4.0%+9.6%+0.0%-5.8%-2.0%-1.0%+0.0%-99.3%+0.0%-25.0%-33.3%
YoY Change+29.1%+35.5%+13.0%+14.0%+3.2%-7.7%-8.6%-2.9%-99.3%-99.3%-99.5%-50.0%
Range$2M$653M
CAGR-78.6%
Avg YoY Growth-22.7%
Median YoY Growth-5.3%
Current Streak2 quarters decline

Frequently Asked Questions

What is Moderna's finance lease liability undiscounted excess amount?
Moderna (MRNA) reported finance lease liability undiscounted excess amount of $2M in Q1 2026.
How has Moderna's finance lease liability undiscounted excess amount changed year-over-year?
Moderna's finance lease liability undiscounted excess amount decreased by 50.0% year-over-year, from $4M to $2M.